法米西克洛维尔通过AhR调节的自来改善血小板激活和血栓形成
Yue Ming1, Qilong Zhou1, Guang Xin1
1Department of Rehabilitation Medicine Center, Natural and Biomimetic Medicine Research Center, Tissue-Orientated Property of Chinese Medicine Key Laboratory of Sichuan Province, West China School of Medicine, West China Hospital, Sichuan University, Keyuan Road 4 No.1, Gaopeng Avenue, Gaoxin District, Chengdu, 610041, Sichuan, China.
Cardiovascular toxicology
|February 10, 2025
概括
芳克洛维尔抑制了基碳化合物受体 (AhR) 以减少血小板激活和血栓形成,为心血管疾病 (CVD) 提供了潜在的新疗法. 这种方法可以减轻当前抗血小板药物的副作用.
科学领域:
- 心血管科学 心血管科学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 心血管疾病 (CVD) 在全球面临重大健康挑战.
- 目前的抗血小板疗法有局限性和副作用.
- 需要新的治疗点和药物来管理心血管疾病.
研究的目的:
- 确定心血管疾病的新型治疗点.
- 调查famciclovir作为治疗心血管疾病的烯碳化合物受体 (AhR) 抑制剂的潜力.
- 评估famciclovir在降低血小板激活和血栓形成方面的疗效.
主要方法:
- 使用基因卡数据库对心血管疾病目标进行查.
- 计算机辅助的药物查和分子对接以确定潜在的抑制剂.
- 在体外实验中对血栓激发的血小板进行了评估,以评估AhR表达,血小板激活,线粒体损伤和氧化应激.
- 使用FeCl3诱导的动脉血栓和中脑动脉封闭模型的体内研究.
主要成果:
- 确定AhR是与心血管疾病相关的潜在目标.
- 帕姆西克洛维尔被确定为一种潜在的AhR抑制剂.
- 芳密克洛维尔抑制了AhR表达和血小板激活,减少了线粒体损伤和氧化应激.
- 口服方米克洛维尔抑制了由血栓激发的血小板聚合,但没有影响凝血或血栓溶解.
- 在体内,famciclovir减轻了动脉和脑血栓的发生.
结论:
- 用famciclovir抑制AhR表达有效地减少了血小板激活和血栓形成.
- 芬西克洛维尔显示出作为心血管疾病潜在治疗策略的前景.
- 这项研究强调了一种通过准AhR来管理心血管疾病的新机制.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
461
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
461
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
601
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
601
01:17Intracellular Signaling Affects Focal Adhesions
2.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.5K
01:22Formation of the Platelet Plug
3.9K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.9K